Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM | BSE: 500420

Expensive Performer

In 1 Starfolio Basket

Download real time

3932.20 -88.30 (-2.20%)

New 52W High in past week

328.2K

NSE+BSE Volume

NSE 23 Jan, 2026 3:31 PM (IST)

Torrent Pharma News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Torrent Pharma from all sources in a single place.

Torrent Pharmaceuticals Ltd.

23 Jan 2026

3932.20

-2.20%

Company Update

Torrent Pharmaceuticals Ltd - 500420 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

BSE India

Update on Acquisition

Torrent Pharmaceuticals Ltd.

23 Jan 2026

3932.20

-2.20%

Company Update

Torrent Pharmaceuticals Ltd - 500420 - Intimation Under Regulation 30

BSE India

Intimation under Regulation 30

Torrent Pharmaceuticals Ltd.

21 Jan 2026

3932.20

-2.20%

Torrent Pharma recognised as new promoter of JB Chemicals; CEO to step down

Business Line

The transaction, executed under a share purchase agreement signed in June 2025, was completed on January 21, 2026

Torrent Pharmaceuticals Ltd. is trading above all available SMAs

Torrent Pharmaceuticals Ltd.

21 Jan 2026

3932.20

-2.20%

Company Update

Torrent Pharmaceuticals Ltd - 500420 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

BSE India

Intimation of acquisition of Equity Shares of J.B. Chemicals & Pharmaceuticals Limited

Torrent Pharmaceuticals Ltd.

19 Jan 2026

3932.20

-2.20%

Company Update

Torrent Pharmaceuticals Ltd - 500420 - Announcement under Regulation 30 (LODR)-Allotment

BSE India

Intimation regarding allotment of Non Convertible Debentures

Torrent Pharmaceuticals Ltd.

19 Jan 2026

3932.20

-2.20%

Company Update

Torrent Pharmaceuticals Ltd - 500420 - Announcement under Regulation 30 (LODR)-Allotment

BSE India

Intimation regarding Issue of Commercial Papers

Torrent Pharmaceuticals Ltd.

17 Jan 2026

3932.20

-2.20%

Torrent Pharma Raises 12,500 cr via Bonds for Buyout of JB Chemicals

Economic Times

Torrent Pharmaceuticals has successfully raised 12,500 crore via debentures, a strategic move to finance its takeover of JB Chemicals & Pharmaceuticals. By issuing commercial papers and non-convertible debentures with varying maturities, Torrent attracted investments from mutual funds, insurance firms, and pension funds. This financing decision underscores Torrent's ambition to enhance its market presence and broaden its therapeutic offerings.

Torrent Pharmaceutic.. has an average target of 3978.00 from 7 brokers.

Torrent Pharmaceuticals Ltd.

14 Jan 2026

3932.20

-2.20%

Torrent Pharma to sell largest acquisition-funding debt this FY, bankers say

Business Line

The company has invited commitment bids for all issues on Friday, and has tied up with large mutual funds and pension funds as anchor investors

Torrent Pharmaceuticals Ltd. is trading above all available SMAs

Torrent Pharmaceuticals Ltd.

10 Jan 2026

3932.20

-2.20%

Torrent Pharma eyes Rs 12,500-crore bond sale next week. Check details

Economic Times

Next week, Torrent Pharmaceuticals is set to launch a hefty debt sale, targeting around 12,500 crore in fundraising. This capital will play a critical role in facilitating the company's acquisition of JB Chemicals & Pharmaceuticals. The strategy includes issuing commercial paper and non-convertible debentures, showcasing the increasing reliance on debt markets for corporate buyouts.

Torrent Pharmaceutic.. has an average target of 3978.00 from 7 brokers.

Torrent Pharmaceuticals Ltd.

08 Jan 2026

3932.20

-2.20%

Torrent Pharma lines up mega 12,500 crore acquisition-funding bond sale

Business Line

The issuance is expected to span maturities of one to five years.

Number of FII/FPI investors increased from 892 to 905 in Dec 2025 qtr.

Is Torrent Pharmaceuticals Ltd. worth buying?

161 Votes:

Buy 73.29%

Sell 16.77%

Hold 9.94%

RESEARCH REPORTS

Buy SEE REPORTS >

Results Update SEE REPORTS >